Ventas (NYSE:VTR) Research Coverage Started at The Goldman Sachs Group

The Goldman Sachs Group assumed coverage on shares of Ventas (NYSE:VTR) in a research report report published on Friday morning, MarketBeat Ratings reports. The brokerage issued a buy rating and a $94.00 price target on the real estate investment trust’s stock.

Several other research firms have also weighed in on VTR. KeyCorp boosted their target price on Ventas from $70.00 to $85.00 and gave the stock an “overweight” rating in a report on Thursday, December 4th. Cantor Fitzgerald reissued an “overweight” rating and issued a $93.00 price objective on shares of Ventas in a research note on Monday, January 5th. Citigroup increased their target price on Ventas from $80.00 to $88.00 and gave the stock a “buy” rating in a report on Tuesday, November 11th. Jefferies Financial Group reaffirmed a “buy” rating and issued a $93.00 price target on shares of Ventas in a report on Monday, December 15th. Finally, Wells Fargo & Company upped their price target on shares of Ventas from $80.00 to $88.00 and gave the stock an “overweight” rating in a research report on Tuesday, November 25th. One investment analyst has rated the stock with a Strong Buy rating, fifteen have issued a Buy rating and three have given a Hold rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $80.65.

Ventas Price Performance

Shares of NYSE:VTR opened at $74.90 on Friday. The company has a debt-to-equity ratio of 1.01, a current ratio of 0.32 and a quick ratio of 0.32. The stock has a market capitalization of $35.18 billion, a P/E ratio of 144.05, a P/E/G ratio of 1.85 and a beta of 0.78. The business has a 50-day moving average of $78.25 and a two-hundred day moving average of $71.42. Ventas has a fifty-two week low of $56.97 and a fifty-two week high of $81.89.

Ventas (NYSE:VTR) last posted its quarterly earnings data on Wednesday, October 29th. The real estate investment trust reported $0.88 earnings per share for the quarter, topping the consensus estimate of $0.87 by $0.01. The business had revenue of $1.49 billion during the quarter, compared to analysts’ expectations of $1.44 billion. Ventas had a return on equity of 2.05% and a net margin of 4.28%.The firm’s revenue was up 20.5% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.80 EPS. Ventas has set its FY 2025 guidance at 3.450-3.480 EPS. On average, equities research analysts predict that Ventas will post 3.4 EPS for the current fiscal year.

Ventas Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, January 15th. Investors of record on Wednesday, December 31st will be issued a $0.48 dividend. This represents a $1.92 dividend on an annualized basis and a yield of 2.6%. The ex-dividend date is Wednesday, December 31st. Ventas’s dividend payout ratio is currently 369.23%.

Insider Buying and Selling at Ventas

In other Ventas news, CEO Debra A. Cafaro sold 10,322 shares of the firm’s stock in a transaction that occurred on Friday, January 2nd. The shares were sold at an average price of $77.26, for a total transaction of $797,477.72. Following the sale, the chief executive officer directly owned 1,145,695 shares in the company, valued at approximately $88,516,395.70. This trade represents a 0.89% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this link. Also, CFO Robert F. Probst sold 29,930 shares of the firm’s stock in a transaction on Friday, January 2nd. The stock was sold at an average price of $77.25, for a total transaction of $2,312,092.50. Following the sale, the chief financial officer owned 138,434 shares in the company, valued at approximately $10,694,026.50. The trade was a 17.78% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Over the last 90 days, insiders sold 713,520 shares of company stock valued at $52,788,577. Corporate insiders own 1.00% of the company’s stock.

Hedge Funds Weigh In On Ventas

A number of large investors have recently modified their holdings of the business. Cloud Capital Management LLC bought a new position in Ventas during the third quarter worth $25,000. GoalVest Advisory LLC acquired a new stake in shares of Ventas during the 4th quarter worth about $26,000. Wiser Advisor Group LLC bought a new stake in shares of Ventas during the 3rd quarter worth about $27,000. True Wealth Design LLC boosted its holdings in shares of Ventas by 1,557.7% during the 3rd quarter. True Wealth Design LLC now owns 431 shares of the real estate investment trust’s stock worth $30,000 after buying an additional 405 shares during the period. Finally, ORG Partners LLC grew its stake in Ventas by 76.1% in the 3rd quarter. ORG Partners LLC now owns 456 shares of the real estate investment trust’s stock valued at $32,000 after buying an additional 197 shares during the last quarter. 94.18% of the stock is currently owned by institutional investors and hedge funds.

Ventas Company Profile

Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.

Ventas’ business model combines property ownership with active asset management and capital markets activity.